/
Johnson & Johnson and its subsidiaries (the Company) have approximately 138,200 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world.
$225.33
$5.47 (-2.37%)
Price from 5 days ago
Margins and capital returns are both well above average: 27.17% operating margin, ROIC at 16.25%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 6.0%, steady but not accelerating.
At 26x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
26.1x earnings, 31.0x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$96.36B
▲ +6.0% YoY
Net Income (TTM)
$21.04B
▲ +90.6% YoY
Op. Margin
26.77%
▲ +3.3pp YoY
ROIC
16.73%
▼ -1.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$17.78B
▼ -0.7% YoY
Op. Cash Flow (TTM)
$22.87B
▲ +1.1% YoY
Net Debt
$32.94B
Cash & Equiv.
$22.05B
5Y CAGR: +2.7%
5Y CAGR: -0.5%
Continue Research